Quest Diagnostics SVP Deppe sells 11,776 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quest Diagnostics (DGX) SVP, Corp. Controller & CAO Michael J. Deppe exercised non-qualified stock options on November 13, 2026: 6,261 at $95.795 per share and 5,515 at $103.57 per share. He sold corresponding lots of 6,261 and 5,515 common shares at $260.17 per share under a Rule 10b5-1 sales plan adopted by him. A separate entry lists 713 shares indirectly through the company’s 401(k) plan; the reported figure is based on the plan’s stock-fund account balance, which includes some money market instruments.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualifed Stock Option (right to buy) F1, F4 | 6,261 | $95.795 | $600K |
| Exercise | Non-Qualifed Stock Option (right to buy) F1, F4 | 5,515 | $103.57 | $571K |
| Exercise | Common Stock F1 | 6,261 | $95.795 | $600K |
| Sale | Common Stock F1 | 6,261 | $260.17 | $1.63M |
| Exercise | Common Stock F1 | 5,515 | $103.57 | $571K |
| Sale | Common Stock F1, F2 | 5,515 | $260.17 | $1.43M |
| Holding | Common Stock F3 | -- | -- | -- |
Footnotes (4)
- F1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- F2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F3. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F4. The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Key Figures
Key Terms
Rule 10b5-1 sales plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What options did DGX SVP Michael J. Deppe exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.